Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Consolidated Net Income: 2011-2024

Historic Consolidated Net Income for Tenax Therapeutics (TENX) over the last 11 years, with Dec 2024 value amounting to -$17.6 million.

  • Tenax Therapeutics' Consolidated Net Income fell 183.07% to -$34.3 million in Q4 2016 from the same period last year, while for Dec 2016 it was -$56.6 million, marking a year-over-year increase of 57.81%. This contributed to the annual value of -$17.6 million for FY2024, which is 126.43% down from last year.
  • Per Tenax Therapeutics' latest filing, its Consolidated Net Income stood at -$17.6 million for FY2024, which was down 126.43% from -$7.8 million recorded in FY2023.
  • Tenax Therapeutics' Consolidated Net Income's 5-year high stood at $11.0 million during FY2022, with a 5-year trough of -$17.6 million in FY2024.
  • For the 3-year period, Tenax Therapeutics' Consolidated Net Income averaged around -$4.8 million, with its median value being -$7.8 million (2023).
  • Data for Tenax Therapeutics' Consolidated Net Income shows a maximum YoY plummeted of 170.36% (in 2023) over the last 5 years.
  • Tenax Therapeutics' Consolidated Net Income (Yearly) stood at -$9.9 million in 2020, then reached $11.0 million in 2022, then crashed by 170.36% to -$7.8 million in 2023, then plummeted by 126.43% to -$17.6 million in 2024.